Open access · CC-BY
via OpenAlex
Alpha-synuclein in skin as a high-quality biomarker for Parkinson's disease
Haoran Peng, Siyuan Chen, Shaopu Wu, Xiaoxue Shi, Jianjun Ma, Hongqi Yang, Xue Li
Journal of the Neurological Sciences · 2023 · ▲ 28 citations
Abstract
Parkinson's disease (PD), the most common neurological motor system disorder, which characterised by the irreversible loss of dopaminergic neurones in the substantia nigra pars compacta, and leads to the deficiency of dopamine in the striatum. Deposited Lewy bodies (LBs) in diseased neurones and nerve terminals are the pathological hallmark of PD, and alpha-synuclein (α-Syn) is the most prominent protein in LBs. The tight association between α-Syn and the molecular pathology of PD has generatly increaed the interest in using the α-Syn species as biomarkers to diagnose early PD. α-Syn is not confined to the central nervous system, it is also present in the peripheral tissues, such as human skin. The assessment of skin α-Syn has the potential to be a diagnostic method that not only has excellent sensitivity, specificity, and reproducibility, but also convenient and acceptable to patients. In this review, we (i) integrate the biochemical, aggregation and structural features of α-Syn; (ii) map the distribution of the α-Syn species present in the brain, biological fluids, and peripheral tissues; and (iii) present a critical and comparative analysis of previous studies that have measured α-Syn in the skin. Finally, we provide an outlook on the future of skin biopsy as a diagnostic approach for PD, and highlight its potential implications for clinical trials, clinical decision-making, treatment strategies as well as the development of new therapies.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.jns.2023.120730
- Canonical
- link ↗
- Fetched
- 2026-10-20 MST
Cite this
APA
Peng, H., Chen, S., Wu, S., Shi, X., Ma, J., Yang, H., & Li, X. (2023). Alpha-synuclein in skin as a high-quality biomarker for Parkinson's disease. <em>Journal of the Neurological Sciences</em>. https://doi.org/10.1016/j.jns.2023.120730
Vancouver
Peng H, Chen S, Wu S, Shi X, Ma J, Yang H, et al. Alpha-synuclein in skin as a high-quality biomarker for Parkinson's disease. Journal of the Neurological Sciences. 2023. doi:10.1016/j.jns.2023.120730.
BibTeX
@article{haoran2023Alphas,
title = {Alpha-synuclein in skin as a high-quality biomarker for Parkinson's disease},
author = {Haoran Peng and Siyuan Chen and Shaopu Wu and Xiaoxue Shi and Jianjun Ma and Hongqi Yang and Xue Li},
journal = {Journal of the Neurological Sciences},
year = {2023},
doi = {10.1016/j.jns.2023.120730},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
npj Parkinson s Disease 2022
Open access · CC-BY
Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson’s disease and other synucleinopathies
Acta Neuropathologica Communications 2014
Open access · CC-BY
Models of α-synuclein aggregation in Parkinson’s disease
Acta Neurologica Scandinavica 2014
Open access · OA
Alpha-synuclein in peripheral tissues and body fluids as a biomarker for Parkinson's disease - a systematic review
Frontiers in Aging Neuroscience 2021
Open access · CC-BY
Biomarkers and the Role of α-Synuclein in Parkinson’s Disease
Experimental and Therapeutic Medicine 2023
Open access · CC-BY
Relationship among α‑synuclein, aging and inflammation in Parkinson's disease (Review)
SLEEP 2020
Preprint · OA